A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle East.
Restrictive dermopathy (RD) is a severe neonatal inherited skin syndrome of which children die shortly after birth. Clinical features include intrauterine growth retardation, taut translucent and easily eroded skin, multiple joint ankylosis and distinct facial features. RD is usually caused by homozygous or compound heterozygous mutations in ZMPSTE24, predicted to cause loss of function of the encoded zinc metalloproteinase STE24. ZMPSTE24 is essential for the processing of the nuclear intermediate filament protein prelamin A. We report two distantly related children from the United Arab Emirates with RD. Remarkably, they lived up to 2 months, suggesting some residual function of the mutant protein. We sought to confirm the diagnosis by thorough microscopic analysis of patient skin, to identify the causative mutation and to study its functional consequences. A skin biopsy was obtained and processed for light and electron microscopy. Peripheral blood leucocytes were used for DNA and RNA isolation, and detection of prelamin A by immunofluorescence. Analysis of the skin confirmed the earlier reported densely packed collagen bundles and lack of elastin fibres. In both patients a homozygous splice site mutation c.627+1G>C in ZMPSTE24 was identified. Analysis of the ZMPSTE24 mRNA revealed an in-frame exon 5 skipping. Accumulation of prelamin A could be detected at the nuclear envelope of patient blood lymphocytes. We thus report the first splice site mutation in ZMPSTE24, which is likely to be a founder mutation in the United Arab Emirates. The accumulation of prelamin A at the nuclear periphery is consistent with defective ZMPSTE24 function. Interestingly, a regular blood sample can be used to investigate prelamin A accumulation.
Sander
C S
CS
Department of Dermatology, Tawam Hospital in Affiliation with John Hopkins medicine, PO Box 15258, Al Ain, United Arab Emirates.
Salman
N
N
van Geel
M
M
Broers
J L V
JL
Al-Rahmani
A
A
Chedid
F
F
Hausser
I
I
Oji
V
V
Al Nuaimi
K
K
Berger
T G
TG
Verstraeten
V L R M
VL
D004547:Elastic Tissue / Q000002:abnormalities*; D018703:Founder Effect; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D034904:Lamin Type A; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D008666:Metalloendopeptidases / Q000235:genetics* / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D011498:Protein Precursors / Q000235:genetics* / Q000378:metabolism; D022821:RNA Splice Sites / Q000235:genetics; D012868:Skin Abnormalities / Q000235:genetics* / Q000473:pathology; D012873:Skin Diseases, Genetic / Q000235:genetics* / Q000473:pathology; D014479:United Arab Emirates
D034904:Lamin Type A; D008565:Membrane Proteins; D009687:Nuclear Proteins; D011498:Protein Precursors; D022821:RNA Splice Sites; C090764:prelamin A; D008666:Metalloendopeptidases; C120130:ZMPSTE24 protein, human